- Raw materials
- Vitamin D analogues
- Pefcalcitol
Pefcalcitol API Manufacturers & Suppliers
0 verified results
Commercial-scale Suppliers
Join our notification list by following this page.
Click the button below to find out more
Click the button below to switch over to the contract services area of Pharmaoffer.
Total market transparency
Supplier trade data access
Buyer / supplier flow comparison
Pefcalcitol | CAS No: 381212-03-9 | GMP-certified suppliers
A medication that is investigated for modulating keratinocyte activity in psoriasis, offering potential benefits in managing this chronic inflammatory skin disorder.
Product Snapshot
- Pefcalcitol is a topical small molecule formulation
- It is primarily investigated for dermatological conditions such as psoriasis
- The compound is currently in the investigational phase and not yet approved by major regulatory authorities
Clinical Overview
Although clinical indications for pefcalcitol have not been formally established, its structural relationship to vitamin D analogues suggests potential modulatory effects on keratinocyte proliferation and differentiation, processes that are often dysregulated in psoriatic lesions. However, specific pharmacodynamic properties and mechanisms of action for pefcalcitol have not been fully elucidated in the literature.
Key absorption, distribution, metabolism, and excretion (ADME) parameters for pefcalcitol, including bioavailability, metabolic pathways, half-life, and excretion routes, have not been comprehensively described in publicly available sources. Consequently, detailed pharmacokinetic profiles remain undocumented.
Safety and toxicity data for pefcalcitol are limited, reflecting its status as an investigational compound without established therapeutic approvals. Potential adverse effects and toxicity profiles have not been systematically reported, emphasizing the need for cautious interpretation in any experimental or clinical setting.
Pefcalcitol has not been approved for commercial use and remains investigational, primarily confined to research studies rather than clinical application. No notable branded formulations exist to date.
From an API sourcing perspective, stringent quality control is essential due to the compound's investigational status and limited commercial availability. Analytical verification of identity, purity, and stability is critical when procuring pefcalcitol for scientific research or formulation development, ensuring compliance with regulatory standards applicable to investigational substances.
Identification & chemistry
| Generic name | Pefcalcitol |
|---|---|
| Molecule type | Small molecule |
| CAS | 381212-03-9 |
| UNII | KT5224XSHW |
| DrugBank ID | DB11786 |
Formulation & handling
- Pefcalcitol is a small molecule vitamin D derivative primarily suitable for oral formulations due to its low water solubility.
- Handling requires consideration of its secosteroid backbone, potentially sensitive to light and oxidative conditions.
- Formulation strategies should address limited aqueous solubility to enhance bioavailability in oral dosage forms.
Regulatory status
Pefcalcitol is a type of Vitamin D analogues
Vitamin D analogues belong to the pharmaceutical category of active pharmaceutical ingredients (APIs) and are widely used in the medical field. These analogues are synthetic compounds designed to mimic the effects of natural vitamin D, a vital nutrient for human health. Vitamin D plays a crucial role in maintaining proper bone health, regulating calcium and phosphorus levels, and supporting the immune system.
Pharmaceutical companies produce various types of vitamin D analogues, each with distinct properties and applications. These analogues are designed to target specific receptors in the body, mimicking the actions of natural vitamin D. By interacting with these receptors, vitamin D analogues can effectively regulate calcium absorption and metabolism, promoting optimal bone health.
One of the significant advantages of using vitamin D analogues as APIs is their enhanced stability and bioavailability compared to natural vitamin D. This allows for better control over dosage and ensures consistent therapeutic effects. Moreover, pharmaceutical-grade analogues undergo rigorous quality control measures to guarantee their purity, safety, and efficacy.
Medical professionals prescribe vitamin D analogues to patients with vitamin D deficiencies, osteoporosis, psoriasis, and other related conditions. These APIs are available in various formulations, including oral tablets, capsules, and topical creams, allowing for flexible and convenient administration.
In summary, vitamin D analogues are a vital category of pharmaceutical APIs widely used to address vitamin D deficiencies and related health conditions. Their synthetic nature, enhanced stability, and targeted actions make them an effective option for maintaining bone health and supporting overall well-being.
